• New epigenetic drug strategy to treat cancer worldpharmanews
    October 29, 2018
    Researchers have discovered that inhibiting CDK9, a DNA transcription regulator, reactivates genes that have been epigenetically silenced by cancer.
PharmaSources Customer Service